Literature DB >> 18720445

Synergy between myogenic and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle construct.

Mariea A Brady1, Mark P Lewis, Vivek Mudera.   

Abstract

In vitro skeletal muscle engineering involves the culture of isolated primary myogenic cells in an environment conducive to the formation of a three-dimensional (3D) tissue construct capable of generating force. Isolated human myogenic cells have been used to study cell-cell interactions, permitting identification of functions intrinsic to skeletal muscle in two dimensions (2D). However, the independent contribution of human myogenic and non-myogenic cell types that comprise skeletal muscle to myogenic cell differentiation, force generation and matrix remodelling has yet to be established in 3D. The objective of this study was to use isolated human myogenic and non-myogenic muscle-derived cells (MDC) seeded in 3D collagen constructs to engineer a biomimetic craniofacial skeletal construct. The aim was to purify the two subpopulations of myogenic and non-myogenic cells from human masseter muscle and quantitate myogenic cell differentiation, force generation and matrix remodelling of the 3D collagen construct. The results showed that both the heterogeneous mixture of cells and the purified myogenic cell population expressed myogenin, indicative of myogenic cell differentiation. Further, there was a synergistic effect as the heterogeneous co-culture of myogenic and non-myogenic cells generated the highest peak force and expressed the most MMP-2 mRNA compared to isolated individual cell populations. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720445     DOI: 10.1002/term.112

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  19 in total

1.  Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury.

Authors:  Benjamin T Corona; Masood A Machingal; Tracy Criswell; Manasi Vadhavkar; Ashley C Dannahower; Christopher Bergman; Weixin Zhao; George J Christ
Journal:  Tissue Eng Part A       Date:  2012-05-10       Impact factor: 3.845

Review 2.  Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.

Authors:  Serge Ostrovidov; Vahid Hosseini; Samad Ahadian; Toshinori Fujie; Selvakumar Prakash Parthiban; Murugan Ramalingam; Hojae Bae; Hirokazu Kaji; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2014-02-24       Impact factor: 6.389

Review 3.  Striated muscle function, regeneration, and repair.

Authors:  I Y Shadrin; A Khodabukus; N Bursac
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

4.  Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells.

Authors:  Jason Wang; Torie Broer; Taylor Chavez; Chris J Zhou; Sabrina Tran; Yu Xiang; Alastair Khodabukus; Yarui Diao; Nenad Bursac
Journal:  Biomaterials       Date:  2022-04-07       Impact factor: 15.304

Review 5.  In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease.

Authors:  Alastair Khodabukus; Neel Prabhu; Jason Wang; Nenad Bursac
Journal:  Adv Healthc Mater       Date:  2018-04-25       Impact factor: 9.933

6.  Protein-engineered biomaterials to generate human skeletal muscle mimics.

Authors:  Debanti Sengupta; Penney M Gilbert; Kyle J Johnson; Helen M Blau; Sarah C Heilshorn
Journal:  Adv Healthc Mater       Date:  2012-09-05       Impact factor: 9.933

7.  Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System.

Authors:  Alec S T Smith; Samantha L Passey; Neil R W Martin; Darren J Player; Vivek Mudera; Linda Greensmith; Mark P Lewis
Journal:  Cells Tissues Organs       Date:  2016-11-09       Impact factor: 2.481

8.  Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection.

Authors:  D Gholobova; M Gerard; L Decroix; L Desender; N Callewaert; P Annaert; L Thorrez
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

9.  Bioactivation of titanium dioxide scaffolds by ALP-functionalization.

Authors:  A Sengottuvelan; P Balasubramanian; J Will; A R Boccaccini
Journal:  Bioact Mater       Date:  2017-03-23

10.  An Assessment of Myotube Morphology, Matrix Deformation, and Myogenic mRNA Expression in Custom-Built and Commercially Available Engineered Muscle Chamber Configurations.

Authors:  Julia M Jones; Darren J Player; Neil R W Martin; Andrew J Capel; Mark P Lewis; Vivek Mudera
Journal:  Front Physiol       Date:  2018-05-08       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.